The recent approval of anti-amyloid pharmaceuticals for the treatment of Alzheimer's disease (AD) has created a pressing need for the ability to accurately identify optimal candidates for anti-amyloid therapy, specifically those with evidence for incipient cognitive decline, since patients with mild cognitive impairment (MCI) may remain stable for several years even with positive AD biomarkers. Using fluorodeoxyglucose PET and biomarker data from 594 ADNI patients, a neural network ensemble was trained to forecast cognition from MCI diagnostic baseline. Training data comprised PET studies of patients with biological AD. The ensemble discriminated between progressive and stable prodromal subjects (MCI with positive amyloid and tau) at baseline with 88.6% area-under-curve, 88.6% (39/44) accuracy, 73.7% (14/19) sensitivity and 100% (25/25) specificity in the test set. It also correctly classified all other test subjects (healthy or AD continuum subjects across the cognitive spectrum) with 86.4% accuracy (206/239), 77.4% sensitivity (33/42) and 88.23% (165/197) specificity. By identifying patients with prodromal AD who will not progress to dementia, our model could significantly reduce overall societal burden and cost if implemented as a screening tool. The model's high positive predictive value in the prodromal test set makes it a practical means for selecting candidates for anti-amyloid therapy and trials.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that severely affects memory, behavior, and cognitive function. Early and accurate diagnosis is crucial for effective intervention, yet detecting subtle changes in the early stages remains a challenge. In this study, we propose a hybrid deep learning-based multi-class classification system for AD using magnetic resonance imaging (MRI). The proposed approach integrates an improved DeepLabV3+ (IDeepLabV3+) model for lesion segmentation, followed by feature extraction using the LeNet-5 model. A novel feature selection method based on average correlation and error probability is employed to enhance classification efficiency. Finally, an Enhanced ResNext (EResNext) model is used to classify AD into four stages: non-dementia (ND), very mild dementia (VMD), mild dementia (MD), and moderate dementia (MOD). The proposed model achieves an accuracy of 98.12%, demonstrating its superior performance over existing methods. The area under the ROC curve (AUC) further validates its effectiveness, with the highest score of 0.97 for moderate dementia. This study highlights the potential of hybrid deep learning models in improving early AD detection and staging, contributing to more accurate clinical diagnosis and better patient care.

Accurate differentiation of pseudoprogression (PsP) from True Progression (TP) following radiotherapy (RT) in glioblastoma patients is crucial for optimal treatment planning. However, this task remains challenging due to the overlapping imaging characteristics of PsP and TP. This study therefore proposes a multimodal deep-learning approach utilizing complementary information from routine anatomical MR images, clinical parameters, and RT treatment planning information for improved predictive accuracy. The approach utilizes a self-supervised Vision Transformer (ViT) to encode multi-sequence MR brain volumes to effectively capture both global and local context from the high dimensional input. The encoder is trained in a self-supervised upstream task on unlabeled glioma MRI datasets from the open BraTS2021, UPenn-GBM, and UCSF-PDGM datasets (n = 2317 MRI studies) to generate compact, clinically relevant representations from FLAIR and T1 post-contrast sequences. These encoded MR inputs are then integrated with clinical data and RT treatment planning information through guided cross-modal attention, improving progression classification accuracy. This work was developed using two datasets from different centers: the Burdenko Glioblastoma Progression Dataset (n = 59) for training and validation, and the GlioCMV progression dataset from the University Hospital Erlangen (UKER) (n = 20) for testing. The proposed method achieved competitive performance, with an AUC of 75.3%, outperforming the current state-of-the-art data-driven approaches. Importantly, the proposed approach relies solely on readily available anatomical MRI sequences, clinical data, and RT treatment planning information, enhancing its clinical feasibility. The proposed approach addresses the challenge of limited data availability for PsP and TP differentiation and could allow for improved clinical decision-making and optimized treatment plans for glioblastoma patients.

This study aims to develop a deep learning algorithm for differentiating aneurysmal subarachnoid hemorrhage (aSAH) from non-aneurysmal subarachnoid hemorrhage (naSAH) using non-contrast computed tomography (NCCT) scans. This retrospective study included 618 patients diagnosed with SAH. The dataset was divided into a training and internal validation cohort (533 cases: aSAH = 305, naSAH = 228) and an external test cohort (85 cases: aSAH = 55, naSAH = 30). Hemorrhage regions were automatically segmented using a U-Net + + architecture. A ResNet-based deep learning model was trained to classify the etiology of SAH. The model achieved robust performance in distinguishing aSAH from naSAH. In the internal validation cohort, it yielded an average sensitivity of 0.898, specificity of 0.877, accuracy of 0.889, Matthews correlation coefficient (MCC) of 0.777, and an area under the curve (AUC) of 0.948 (95% CI: 0.929-0.967). In the external test cohort, the model demonstrated an average sensitivity of 0.891, specificity of 0.880, accuracy of 0.887, MCC of 0.761, and AUC of 0.914 (95% CI: 0.889-0.940), outperforming junior radiologists (average accuracy: 0.836; MCC: 0.660). The study presents a deep learning architecture capable of accurately identifying SAH etiology from NCCT scans. The model's high diagnostic performance highlights its potential to support rapid and precise clinical decision-making in emergency settings. Question Differentiating aneurysmal from naSAH is crucial for timely treatment, yet existing imaging modalities are not universally accessible or convenient for rapid diagnosis. Findings A ResNet-variant-based deep learning model utilizing non-contrast CT scans demonstrated high accuracy in classifying SAH etiology and enhanced junior radiologists' diagnostic performance. Clinical relevance AI-driven analysis of non-contrast CT scans provides a fast, cost-effective, and non-invasive solution for preoperative SAH diagnosis. This approach facilitates early identification of patients needing aneurysm surgery while minimizing unnecessary angiography in non-aneurysmal cases, enhancing clinical workflow efficiency.

By helping the neurosurgeon create treatment strategies that increase the survival rate, automotive diagnosis and CT (Computed Tomography) hemorrhage segmentation (CT) could be beneficial. Owing to the significance of medical image segmentation and the difficulties in carrying out human operations, a wide variety of automated techniques for this purpose have been developed, with a primary focus on particular image modalities. In this paper, MUNet (Multiclass-UNet) based Intracranial Hemorrhage Segmentation and Classification Framework (IHSNet) is proposed to successfully segment multiple kinds of hemorrhages while the fully connected layers help in classifying the type of hemorrhages.The segmentation accuracy rates for hemorrhages are 98.53% with classification accuracy stands at 98.71% when using the suggested approach. There is potential for this suggested approach to be expanded in the future to handle further medical picture segmentation issues. Intraventricular hemorrhage (IVH), Epidural hemorrhage (EDH), Intraparenchymal hemorrhage (IPH), Subdural hemorrhage (SDH), Subarachnoid hemorrhage (SAH) are the subtypes involved in intracranial hemorrhage (ICH) whose DICE coefficients are 0.77, 0.84, 0.64, 0.80, and 0.92 respectively.The proposed method has great deal of clinical application potential for computer-aided diagnostics, which can be expanded in the future to handle further medical picture segmentation and to tackle with the involved issues.

Artificial intelligence (AI) tools for radiology are commonly unmonitored once deployed. The lack of real-time case-by-case assessments of AI prediction confidence requires users to independently distinguish between trustworthy and unreliable AI predictions, which increases cognitive burden, reduces productivity, and potentially leads to misdiagnoses. To address these challenges, we introduce Ensembled Monitoring Model (EMM), a framework inspired by clinical consensus practices using multiple expert reviews. Designed specifically for black-box commercial AI products, EMM operates independently without requiring access to internal AI components or intermediate outputs, while still providing robust confidence measurements. Using intracranial hemorrhage detection as our test case on a large, diverse dataset of 2919 studies, we demonstrate that EMM successfully categorizes confidence in the AI-generated prediction, suggesting different actions and helping improve the overall performance of AI tools to ultimately reduce cognitive burden. Importantly, we provide key technical considerations and best practices for successfully translating EMM into clinical settings.

To evaluate the prognosis of patients with traumatic brain injury according to the Computed Tomography (CT) findings of skull fracture and cerebral parenchymal hemorrhage. Retrospectively collected data from adult patients who received non-surgical or surgical treatment after the first CT scan with craniocerebral injuries from January 2020 to August 2021. The radiomics features were extracted by Pyradiomics. Dimensionality reduction was then performed using the max relevance and min-redundancy algorithm (mRMR) and the least absolute shrinkage and selection operator (LASSO), with ten-fold cross-validation to select the best radiomics features. Three parsimonious machine learning classifiers, multinomial logistic regression (LR), a support vector machine (SVM), and a naive Bayes (Gaussian distribution), were used to construct radiomics models. A personalized emergency prognostic nomogram for cranial injuries was erected using a logistic regression model based on selected radiomic labels and patients' baseline information at emergency admission. The mRMR algorithm and the LASSO regression model finally extracted 22 top-ranked radiological features and based on these image histological features, the emergency brain injury prediction model was built with SVM, LG, and naive Bayesian classifiers, respectively. The SVM model showed the largest AUC area in training cohort for the three classifications, indicating that the SVM model is more stable and accurate. Moreover, a nomogram prediction model for GOS prognostic score in patients was constructed. We established a nomogram for predicting patients' prognosis through radiomic features and clinical characteristics, provides some data support and guidance for clinical prediction of patients' brain injury prognosis and intervention.

Early and precise diagnosis of dyslexia is crucial for implementing timely intervention to reduce its effects. Timely identification can improve the individual's academic and cognitive performance. Traditional dyslexia detection (DD) relies on lengthy, subjective, restricted behavioral evaluations and interviews. Due to the limitations, deep learning (DL) models have been explored to improve DD by analyzing complex neurological, behavioral, and visual data. DL architectures, including convolutional neural networks (CNNs) and vision transformers (ViTs), encounter challenges in extracting meaningful patterns from cross-modality data. The lack of model interpretability and limited computational power restricts these models' generalizability across diverse datasets. To overcome these limitations, we propose an innovative model for DD using magnetic resonance imaging (MRI), electroencephalography (EEG), and handwriting images. We introduce a model, leveraging hybrid transformer-based feature extraction, including SWIN-Linformer for MRI, LeViT-Performer for handwriting images, and graph transformer networks (GTNs) with multi-attention mechanisms for EEG data. A multi-modal attention-based feature fusion network was used to fuse the extracted features in order to guarantee the integration of key multi-modal features. We enhance Dartbooster XGBoost (DXB)-based classification using Bayesian optimization with Hyperband (BOHB) algorithm. In order to reduce computational overhead, we employ a quantization-aware training technique. The local interpretable model-agnostic explanations (LIME) technique and gradient-weighted class activation mapping (Grad-CAM) were adopted to enable model interpretability. Five public repositories were used to train and test the proposed model. The experimental outcomes demonstrated that the proposed model achieves an accuracy of 99.8% with limited computational overhead, outperforming baseline models. It sets a novel standard for DD, offering potential for early identification and timely intervention. In the future, advanced feature fusion and quantization techniques can be utilized to achieve optimal results in resource-constrained environments.

Recently, Ultra-High Field MRI (UHF-MRI) has become more available and one of the best tools to study the brain. One common step in quantitative neuroimaging is the brain segmentation. However, the differences between UHF-MRI and 1.5-3T images are such that the automatic segmentation techniques optimized at these field strengths usually produce unsatisfactory segmentation results for UHF images. It has been particularly challenging to perform quantitative analyses as typically done with 1.5-3T data, considerably limiting the potential of UHF-MRI. Hence, we propose a novel Deep Learning (DL)-based segmentation technique called GOUHFI: Generalized and Optimized segmentation tool for Ultra-High Field Images, designed to segment UHF images of various contrasts and resolutions. For training, we used a total of 206 label maps from four datasets acquired at 3T, 7T and 9.4T. In contrast to most DL strategies, we used a previously proposed domain randomization approach, where synthetic images generated from the label maps were used for training a 3D U-Net. GOUHFI was tested on seven different datasets and compared to techniques like FastSurferVINN and CEREBRUM-7T. GOUHFI was able to the segment six contrasts and seven resolutions tested at 3T, 7T and 9.4T. Average Dice-Sorensen Similarity Coefficient (DSC) scores of 0.87, 0.84, 0.91 were computed against the ground truth segmentations at 3T, 7T and 9.4T. Moreover, GOUHFI demonstrated impressive resistance to the typical inhomogeneities observed at UHF-MRI, making it a new powerful segmentation tool that allows to apply the usual quantitative analysis pipelines also at UHF. Ultimately, GOUHFI is a promising new segmentation tool, being the first of its kind proposing a contrast- and resolution-agnostic alternative for UHF-MRI, making it the forthcoming alternative for neuroscientists working with UHF-MRI or even lower field strengths.

Medical imaging constitutes critical information in the diagnostic and prognostic evaluation of patients, as it serves to uncover a broad spectrum of pathologies and deviances. Clinical practitioners who carry out medical image screening are primarily reliant on their knowledge and experience for disease diagnosis. Convolutional Neural Networks (CNNs) hold the potential to serve as a formidable decision-support tool in the realm of medical image analysis due to their high capacity to extract hierarchical features and effectuate direct classification and segmentation from image data. However, CNNs contain a myriad of hyperparameters and optimizing these hyperparameters poses a major obstacle to the effective implementation of CNNs. In this work, a two-phase Bayesian Optimization-derived Scheduling (BOS) approach is proposed for hyperparameter optimization for the head and cancerous tissue segmentation tasks. We proposed this two-phase BOS approach to incorporate both rapid convergences in the first training phase and slower (but without overfitting) improvements in the last training phase. Furthermore, we found that batch size and learning rate have a significant impact on the training process, but optimizing them separately can lead to sub-optimal hyperparameter combinations. Therefore, batch size and learning rate have been coupled as the batch size to learning rate (B2L) ratio and utilized in the optimization process to optimize both simultaneously. The optimized hyperparameters have been tested for a three-dimensional V-Net model with computed tomography (CT) and positron emission tomography (PET) scans to segment and classify cancerous and noncancerous tissues. The results of 10-fold cross-validation indicate that the optimal batch size to learning rate (B2L) ratio for each phase of the training method can improve the overall medical image segmentation performance.